Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Personalised oncogenomics: Is a precision approach necessary for every cancer or is there a therapy-driven bottleneck?


29 Sep 2019


Molecular tumour board: Where do we stand? What’s next?


David Huntsman


D. Huntsman

Author affiliations

  • Department Pathology And Laboratory Medicine, British Columbia Cancer Agency, V5Z 4E6 - Vancouver/CA


Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings